Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Eugene E. Wright"'
Autor:
Jr, Eugene E Wright
Publikováno v:
Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy; Sep2024, Vol. 17, p3477-3480, 4p
Autor:
Susanne B, Nicholas, Eugene E, Wright, Liana K, Billings, Estela, Ambriz, Patrick, Gee, Terry, Peeler
Publikováno v:
Advances in Therapy. 40:1-18
Comorbid type 2 diabetes mellitus (T2D) and chronic kidney disease (CKD) is associated with poor health outcomes and a high economic burden. Management of these conditions remains a significant challenge for current healthcare systems. The objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9a35a8d4bd9626d6a6201415dcc6d38
https://doi.org/10.1007/s12325-022-02325-9
https://doi.org/10.1007/s12325-022-02325-9
Publikováno v:
Diabetes Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6308e26fd9f7b819803f102da593cfaa
https://doi.org/10.1007/s13300-023-01416-2
https://doi.org/10.1007/s13300-023-01416-2
Autor:
Andrea M. Yeung, Jingtong Huang, Ambarish Pandey, Ibrahim A. Hashim, David Kerr, Rodica Pop-Busui, Connie M. Rhee, Viral N. Shah, Lia Bally, Antoni Bayes-Genis, Yong Mong Bee, Richard Bergenstal, Javed Butler, G. Alexander Fleming, Gregory Gilbert, Stephen J. Greene, Mikhail N. Kosiborod, Lawrence A. Leiter, Boris Mankovsky, Thomas W. Martens, Chantal Mathieu, Viswanathan Mohan, Kershaw V. Patel, Anne Peters, Eun-Jung Rhee, Giuseppe M.C. Rosano, David B. Sacks, Yader Sandoval, Jane Jeffrie Seley, Oliver Schnell, Guillermo Umpierrez, Kayo Waki, Eugene E. Wright, Alan H.B. Wu, David C. Klonoff
Publikováno v:
Progress in Cardiovascular Diseases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e74964bd1841481abce12b5e8b1e8ec
https://doi.org/10.1016/j.pcad.2023.05.002
https://doi.org/10.1016/j.pcad.2023.05.002
Publikováno v:
Clinical Diabetes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad22980297c50c19b9af3a715ff4093d
https://doi.org/10.2337/cd22-0114
https://doi.org/10.2337/cd22-0114
Publikováno v:
Postgraduate Medicine. 134:376-387
Patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) are at high risk of CKD progression and cardiovascular (CV) disease. Prevalence of CKD in patients with T2D is currently around 40% and continues to grow. The increasing number of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::933612907e76d80151ac50a822fedc4d
https://doi.org/10.1080/00325481.2021.2009726
https://doi.org/10.1080/00325481.2021.2009726
Publikováno v:
The American Journal of Managed Care. 27:e372-e377
OBJECTIVES We evaluated the effects of acquiring a flash continuous glucose monitoring (CGM) system in the population with type 2 diabetes (T2D) treated with basal or noninsulin therapy. STUDY DESIGN This was a retrospective database analysis of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9af730b32e1a60b108e981f1cbb85bc8
https://doi.org/10.37765/ajmc.2021.88780
https://doi.org/10.37765/ajmc.2021.88780
Publikováno v:
Endocrine Reviews
Insulin has been available for the treatment of diabetes for almost a century, and the variety of insulin choices today represents many years of discovery and innovation. Insulin has gone from poorly defined extracts of animal pancreata to pure and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f217190ef16b851ecda6db7cef222b02
https://doi.org/10.1210/endrev/bnaa015
https://doi.org/10.1210/endrev/bnaa015
Publikováno v:
Clinical Diabetes : A Publication of the American Diabetes Association
The A1C metric has been the gold standard for assessing glycemia for decades. This biologic assay, based on averaging, is fraught with limitations and may be giving way to more holistic approaches. This article reviews glycemic time in range as the n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbb1f9375ced00f234eb648cf2d111bd
http://europepmc.org/articles/PMC7755049
http://europepmc.org/articles/PMC7755049
Autor:
Eugene E. Wright, Romain Raymond, Paulos Berhanu, Timothy S. Bailey, Jodi Strong, Jasvinder Gill, Pierre Evenou
Publikováno v:
Diabetes Spectrum : A Publication of the American Diabetes Association
Background ACHIEVE Control, a prospective, open-label, randomized, pragmatic, real-life study in insulin-naive people with type 2 diabetes (A1C 8.0–11.0%), demonstrated superiority of insulin glargine 300 units/mL (Gla-300) versus first-generation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f94e5891406d481f8f72cf8689203419
https://pubmed.ncbi.nlm.nih.gov/34866875
https://pubmed.ncbi.nlm.nih.gov/34866875